Track cost pressure
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Explore British National Formulary presentations, drill into dispensing trend data, and identify which pharmacies drive the greatest usage of each medicine.
| Presentation | Product | Chemical substance | Chapter | Items dispensed |
|---|---|---|---|---|
|
Eno effervescent powder 5g sachets
010102100BBATA0
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
|
Entrocalm Heartburn and Indigestion Relief oral suspension
0101021B0BPAAAH
|
Entrocalm (Alginic acid) | Alginic acid compound preparations | Gastro-Intestinal System | No data available |
|
Entrocalm tablets
0104010H0BHAAAK
|
Entrocalm (Kaolin) | Kaolin light | Gastro-Intestinal System | No data available |
|
Entrolax Constipation Relief 5mg gastro-resistant tablets
0106020C0BHAAAA
|
Entrolax | Bisacodyl | Gastro-Intestinal System | No data available |
|
Entyvio 108mg/0.68ml inj pre-filled syringes
0105030A0BBABAB
|
Entyvio | Vedolizumab | Gastro-Intestinal System | No data available |
|
Entyvio 108mg/0.68ml solution for injection pre-filled pens
0105030A0BBACAC
|
Entyvio | Vedolizumab | Gastro-Intestinal System | No data available |
|
Entyvio 300mg pdr for concentrate for inf vials
0105030A0BBAAAA
|
Entyvio | Vedolizumab | Gastro-Intestinal System | No data available |
|
Equilon 135mg tablets
0102000P0BFAAAB
|
Equilon | Mebeverine hydrochloride | Gastro-Intestinal System | No data available |
|
Equilon Herbal 0.2ml gastro-resistant capsules
0102000T0BGAAAA
|
Equilon Herbal | Peppermint oil | Gastro-Intestinal System | No data available |
|
Ex-Lax Senna 12mg pills
0106020M0BIABAS
|
Ex-Lax | Senna | Gastro-Intestinal System | No data available |
|
Ex-Lax Senna 15mg tablets
0106020M0BIAAAP
|
Ex-Lax | Senna | Gastro-Intestinal System | No data available |
|
Fam-Lax Phenolphthalein tablets
0106020U0BBAAAA
|
Fam-Lax | Phenolphthalein and rhubarb | Gastro-Intestinal System | No data available |
|
Famotidine 10mg tablets
0103010H0AAACAC
|
Famotidine | Famotidine | Gastro-Intestinal System | No data available |
|
Fletchers Arachis oil 130ml enema
0106030A0BBAAAA
|
Fletchers Arach oil | Arachis oil | Gastro-Intestinal System | No data available |
|
Fletchers Enemette 5ml enema
0106020I0BDAAAG
|
Fletchers Enemette | Docusate sodium | Gastro-Intestinal System | No data available |
|
Fletchers phosphate enema 128ml long tube
0106040N0BBAAAA
|
Fletchers phosphate | Phosphates (Rectal) | Gastro-Intestinal System | No data available |
|
Fletchers phosphate enema 128ml standard tube
0106040N0BBABAB
|
Fletchers phosphate | Phosphates (Rectal) | Gastro-Intestinal System | No data available |
|
Fybogel Orange 3.5g effervescent granules sachets SF
0106010E0BBABAH
|
Fybogel | Ispaghula husk | Gastro-Intestinal System | No data available |
|
Galenamet 400mg tablets
0103010D0BFABAB
|
Galenamet | Cimetidine | Gastro-Intestinal System | No data available |
|
Galpharm 3-In-1 Antacid chewable tablets
010102100BBAXA0
|
Proprietary compound preparation BNF 0101021 | Compound alginates and proprietary indigestion preparations | Gastro-Intestinal System | No data available |
|
Galpharm Diarrhoea Relief 2mg capsules
0104020L0BMAAAA
|
Galpharm Diarrhoea Relief | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Galpharm Dual Action Diarrhoea Relief pack
0104020L0BPAAAM
|
Galpharm Dual Action Diarrhoea | Loperamide hydrochloride | Gastro-Intestinal System | No data available |
|
Galpharm Peppermint Antacid tablets
0101021C0BNAAAF
|
Galpharm (Calcium carbonate) | Calcium carbonate | Gastro-Intestinal System | No data available |
|
Gastrocote chewable tablets
0101021B0BCAAAC
|
Gastrocote | Alginic acid compound preparations | Gastro-Intestinal System | No data available |
|
Gavilast Heartburn and Indigestion 75mg tablets
0103010T0BUABAP
|
Gavilast | Ranitidine hydrochloride | Gastro-Intestinal System | No data available |
Link medicine usage to pharmacy and prescriber behaviour to find optimisation opportunities.
Identify presentations with rising spend and create intervention plans focused on switching opportunities or formulary alignment.
Cross-reference high-volume medicines with local health priorities and prescriber activity to target support programs.